Developing a Clinically Relevant Tissue Engineered Heart Valve—A Review of Current Approaches

Abstract

Tissue engineered heart valves (TEHVs) have the potential to address the shortcomings of current implants through the combination of cells and bioactive biomaterials that promote growth and proper mechanical function in physiological conditions. The ideal TEHV should be anti-thrombogenic, biocompatible, durable, and resistant to calcification, and should exhibit a physiological hemodynamic profile. In addition, TEHVs may possess the capability to integrate and grow with somatic growth, eliminating the need for multiple surgeries children must undergo. Thus, this review assesses clinically available heart valve prostheses, outlines the design criteria for developing a heart valve, and evaluates three types of biomaterials (decellularized, natural, and synthetic) for tissue engineering heart valves. While significant progress has been made in biomaterials and fabrication techniques, a viable tissue engineered heart valve has yet to be translated into a clinical product. Thus, current strategies and future perspectives are also discussed to facilitate the development of new approaches and considerations for heart valve tissue engineering.

Heart valve tissue engineering can address limitations of current implants through the combination of cells and biomaterials that promote growth and mechanical function in physiological conditions. This Review assesses current valve prosthesis, outlines the design criteria for developing a valve, evaluates three types of biomaterials (decellularized, natural, and synthetic), and discusses current strategies and future perspectives for valve tissue engineering.

http://ift.tt/2BjgjQb